Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade | Science | 2017 | 3.3K |
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation | New England Journal of Medicine | 2017 | 1.1K |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis | JAMA - Journal of the American Medical Association | 2007 | 928 |
Prevalence of oral HPV infection in the United States, 2009-2010 | JAMA - Journal of the American Medical Association | 2012 | 718 |
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells | Cancer Cell | 2013 | 506 |
Cytogenetics in acute leukemia | Blood Reviews | 2004 | 506 |
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study | Journal of Clinical Oncology | 2000 | 501 |
Side effects of adjuvant treatment of breast cancer | New England Journal of Medicine | 2001 | 488 |
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 399 |
What does it take to make a natural killer? | Nature Reviews Immunology | 2003 | 388 |
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer | Journal of Clinical Oncology | 2001 | 375 |
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells | Blood | 2002 | 341 |
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 291 |
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations | Gastroenterology | 2014 | 269 |
Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability | Genome Research | 2014 | 259 |
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer | Gut | 2018 | 255 |
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas | Oral Oncology | 2013 | 245 |
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1) | Molecular and Cellular Biology | 2006 | 236 |
Comprehensive control of human papillomavirus infections and related diseases | Vaccine | 2013 | 230 |
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes | Gastroenterology | 2015 | 219 |
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations | Biology of Blood and Marrow Transplantation | 2014 | 218 |
Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis | Vaccine | 2012 | 191 |
An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor | Cancer Research | 2005 | 183 |
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients | Journal of Clinical Oncology | 2006 | 173 |
Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue | Immunity | 2010 | 167 |